{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:31:11Z","timestamp":1759537871800,"version":"build-2065373602"},"reference-count":20,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Epidemiol Community Health"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:p>STUDY OBJECTIVE: To investigate whether there has been an increase of venous thromboembolism (VTE) mortality in European countries, concurrent with the replacement of second generation by third generation combined oral contraceptives (COCs). Such an increase has been predicted, and reportedly detected, because published studies have detected an increased incidence of VTE associated with third generation rather than second generation COC use. DESIGN: Data were collected on population and annual VTE mortality in women 15-34 and 35-49 years old, and on second and third generation COC sales, from 1981 to 1994 in 13 European countries. Data from the seven most populous countries were analysed by linear regression of annual VTE mortality, in the 15-34 and 15-49 age groups, with respect to calculated total and third generation COC use rates, and the regression coefficients used to estimate mortality differences between second generation users and non-users and between third and second generation users, respectively. MAIN RESULTS: The estimated mortality differences in all seven countries had confidence intervals wide enough to contain both zero and the excess mortalities expected from the results of published studies. This was true both for the mortality difference between third and second generation COC users and for that between second generation users and COC non-users. CONCLUSIONS: Mortality differences of the size expected from the published studies cannot be measured using annual national VTE mortality and COC sales data alone, because of residual interannual variation in VTE mortality, and possibly confounding between rising third generation market share and total COC use.<\/jats:p>","DOI":"10.1136\/jech.51.6.630","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T15:10:54Z","timestamp":1226502654000},"page":"630-635","source":"Crossref","is-referenced-by-count":6,"title":["Mortality from venous thromboembolism among young women in Europe: no evidence for any effect of third generation oral contraceptives."],"prefix":"10.1136","volume":"51","author":[{"given":"R D","family":"Farmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R B","family":"Newson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Lawrenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Tyrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1997,12,1]]},"reference":[{"key":"ref_1","first-page":"158993","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick, H.; Jick, S.S.; Gurewich, V.; Myers, M.W.; Vasilakis, C.","year":"1995","unstructured":"Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995;346: 158993.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"World Health Organisation Collarorative Study on Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","unstructured":"Farley TMM, Meirik 0, Chang CL, Marmot MG, Poulter NR. World Health Organisation Collarorative Study on Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995;346:1582-8.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study","volume":"312","author":"Spitzer, W.O.; Lewis, M.A.; Heinemann, L.A.J.; Thorogood, M.; MacRae, K.D.","year":"1996","unstructured":"Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996;312:83-8.","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement of factor V Leiden mutation on the risk of deep vein thrombosis associated with oral contraceptives containing a third generation progestagen","volume":"346","author":"Bloemenkamp, K.W.M.; Rosendaal, F.R.; Helmerhorst, F.M.; Buller, H.R.; Vandenbroucke, J.P.","year":"1995","unstructured":"Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement of factor V Leiden mutation on the risk of deep vein thrombosis associated with oral contraceptives containing a third generation progestagen. Lancet 1995;346: 1593-6.","journal-title":"Lancet"},{"key":"ref_5","first-page":"1589","article-title":"Third generation oral contraceptives - the controversy","volume":"311","author":"Carnall, D.; Karcher, H.; Lie, L.G.; Sheldon, T.; Spurgeon, D.; Josefson, D.","year":"1995","unstructured":"Carnall D, Karcher H, Lie LG, Sheldon T, Spurgeon D, Josefson D, et al. Third generation oral contraceptives - the controversy. BM3r 1995;311:1589-90."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"with the Transnational Research Group on Oral Contraceptives and the Health of Young Women. The increased risk of venous thromboembolism and the use of third generation progestogens: the role of bias in observational research","volume":"54","author":"Lewis, M.A.; Heinemann, L.A.J.; MacRae, K.D.; Bruppacher, R.; Spitzer, W.","year":"1996","unstructured":"Lewis MA, Heinemann LAJ, MacRae KD, Bruppacher R, Spitzer W, with the Transnational Research Group on Oral Contraceptives and the Health of Young Women. The increased risk of venous thromboembolism and the use of third generation progestogens: the role of bias in observational research. Contraception 1996;54:5-13.","journal-title":"Contraception"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.312.7023.88","article-title":"Third generation oral contraceptives and the risk of myocardial infarction: an international case-control study","volume":"312","author":"Lewis, M.A.; Spitzer, W.O.; Heinemann, L.A.J.; Bruppacher, MacRae K.D.; R, Thorogood; M.","year":"1996","unstructured":"Lewis MA, Spitzer WO, Heinemann LAJ, MacRae KD Bruppacher R, Thorogood M. Third generation oral contraceptives and the risk of myocardial infarction: an international case-control study. BMJ 1996;312:88-90.","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/bmj.312.7023.68","article-title":"Third generation oral contraception and venous thromboembolism","volume":"312","author":"McPherson, K.","year":"1996","unstructured":"McPherson K. Third generation oral contraception and venous thromboembolism. BMJ 1996;312:68-9.","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(96)24032-2","article-title":"Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands","volume":"348","year":"1996","unstructured":"Vandenbroucke JP, Bloemenkamp KWM, Helmerhorst FM, Rosendaal FR. Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands. Lancet 1996;348:401-2.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0140-6736(05)65016-7","article-title":"Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales","volume":"348","author":"Thomas, S.H.L.","year":"1996","unstructured":"Thomas SHL. Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales. Lancet 1996;348:402.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0140-6736(96)24042-5","article-title":"Oral contraceptives and mortality from venous thromboembolism","volume":"348","author":"Farmer, R.; Lewis, M.","year":"1996","unstructured":"Farmer R, Lewis M. Oral contraceptives and mortality from venous thromboembolism. Lancet 1996;348:1095.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0140-6736(05)64436-4","article-title":"Oral contraceptives and mortality from venous thromboembolism","volume":"348","author":"RHW, Van Lunsen","year":"1996","unstructured":"Van Lunsen RHW. Oral contraceptives and mortality from venous thromboembolism. Lancet 1996;348:1095-6.","journal-title":"Lancet"},{"key":"ref_13","first-page":"18","article-title":"catalogue","author":"HData, Rai","year":"1995","unstructured":"Rai H, ed. Data catalogue. 1st ed. London: IMS Global Services, 1995:18-30.","edition":"1st ed"},{"key":"ref_14","article-title":"SASISTAT Software: The GENMOD Procedure, Release 6.09","author":"Carolina:","year":"1993","unstructured":"SAS Institute Inc. SAS Technical Report P-243, SASISTAT Software: The GENMOD Procedure, Release 6.09. Cary, North Carolina: SAS Institute Inc, 1993."},{"issue":"20","key":"ref_15","article-title":"Population Censuses and Surveys (OPCS). Mortality statistics: cause","volume":"2","author":"Office of","year":"1993","unstructured":"Office of Population Censuses and Surveys (OPCS). Mortality statistics: cause 1993, series DH2 no 20. London: HMSO, 1995:x-xi."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/01443619509015499","article-title":"The risk of venous thromboembolism associated with low oestrogen oral contraceptives","volume":"15","author":"Farmer, R.D.T.; Preston, T.D.","year":"1995","unstructured":"Farmer RDT, Preston TD. The risk of venous thromboembolism associated with low oestrogen oral contraceptives. J Obstet Gynaecol 1995;15:195-200.","journal-title":"J Obstet Gynaecol"},{"key":"ref_17","first-page":"117","article-title":"Thromboembolism","volume-title":"disorders in obstetric practice","author":"de Swiet M","year":"1995","unstructured":"de Swiet M. Thromboembolism. In: de Swiet M, ed. Medical disorders in obstetric practice. 3rd ed. Oxford: Blackwell Science, 1995:117-42.","edition":"3rd ed"},{"key":"ref_18","first-page":"413","article-title":"Oral contraceptives and venous thromboembolism","volume":"109","author":"Paul, C.","year":"1996","unstructured":"Paul C. Oral contraceptives and venous thromboembolism. NZMedJ 1996;109:413-15.","journal-title":"NZMedJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/oxfordjournals.aje.a112803","article-title":"Increased risk of venous thrombosis due to oral contraceptives: a further report","volume":"110","author":"Maguire, M.G.; Tonascia, J.; Sartwell, P.E.; Stolley, P.D.; Tockman, M.S.","year":"1979","unstructured":"Maguire MG, Tonascia J, Sartwell PE, Stolley PD, Tockman MS. Increased risk of venous thrombosis due to oral contraceptives: a further report. Am 7 Epidemiol 1979; 110: 188-95.","journal-title":"Am 7 Epidemiol"},{"key":"ref_20","first-page":"1097","article-title":"Author's reply","volume":"348","author":"Thomas, S.H.L.","year":"1996","unstructured":"Thomas SHL. Author's reply. Lancet 1996;348:1097.","journal-title":"Lancet"}],"container-title":["Journal of Epidemiology and Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jech.51.6.630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:37:24Z","timestamp":1759480644000},"score":1,"resource":{"primary":{"URL":"https:\/\/jech.bmj.com\/lookup\/doi\/10.1136\/jech.51.6.630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1997,12,1]]},"published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1136\/jech.51.6.630"],"URL":"https:\/\/doi.org\/10.1136\/jech.51.6.630","relation":{},"ISSN":["0143-005X","1470-2738"],"issn-type":[{"type":"print","value":"0143-005X"},{"type":"electronic","value":"1470-2738"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}